Instrument Inactif

Communiqués CM LIFE28 Nasdaq

Actions

CMIIU

US1258422039

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Standard BioTools Stockholders Approve Merger with SomaLogic	05/01	AQ
SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting	05/01	PR
Madryn Asset Management Demands SomaLogic’s Board Address Repeated, Unprecedented Adjournments of Tainted Special Meeting	05/01	BU
Madryn Asset Management Addresses SomaLogic’s Apparent Failure to Obtain Requisite Shareholder Support for the Proposed Merger with Standard BioTools	04/01	BU
Proxy Advisory Firm Egan-Jones Recommends SomaLogic Shareholders Vote Against Proposed Merger with Standard BioTools	03/01	BU
SomaLogic Urges Stockholders to Maximize Value of Their Investment by Voting "FOR" Pending Merger with Standard BioTools	02/01	PR
Madryn Asset Management Highlights Increasing Public Shareholder Opposition to Value-Destructive SomaLogic Merger and Calls on Company to Make Additional Disclosures	30/12	BU
Leading Independent Proxy Advisory Firms Glass Lewis and ISS Both Recommend SomaLogic Stockholders Vote "FOR" Proposed Merger with Standard BioTools	29/12	PR
SomaLogic Board Reiterates Value-Maximizing Transaction with Standard BioTools is in Best Interests of All Stockholders	29/12	PR
Dr. Larry Gold and Dr. Jason Cleveland Issue Open Letter to SomaLogic Stockholders Opposing SomaLogic's Proposed Merger with Standard BioTools	28/12	PR
SomaLogic : Merger Agreement - Form 8-K	26/12	PU
SomaLogic Issues Statement Correcting Madryn Asset Management's Misleading Disclosure	26/12	PR
Madryn Asset Management Releases Evidence That SomaLogic Ran a Flawed and Incomplete Review of Alternatives	26/12	BU
Madryn Asset Management Sends Letter to ISS Respectfully Requesting it Withdraw “Cautionary Support” for SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools	24/12	BU
Madryn Asset Management Reiterates Alternative Path to SomaLogic’s Value-Destructive Proposed Merger with Standard BioTools	23/12	BU
ISS Recommends SomaLogic Stockholders Vote “FOR” Proposed Merger with Standard BioTools	23/12	AQ
Madryn Asset Management Highlights Newly-Disclosed Conflicts of Interest Related to Proposed SomaLogic Merger with Standard BioTools	22/12	BU
SomaLogic Issues Letter to Stockholders Reiterating Recommendation for Value Maximizing Merger with Standard BioTools	21/12	AQ
Madryn Asset Management Issues Letter to Shareholders Correcting False and Misleading Statements in SomaLogic’s Recent Investor Presentation	21/12	BU
Skye Fund III Issues Letter Regarding Opposition to SomaLogic’s Proposed Merger with Standard BioTools	20/12	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués CM LIFE28 Nasdaq

Actions

CMIIU

US1258422039

Communiqués

Filtres